Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Robot-Assisted Surgery Helps Cancer Patients Lead Normal Lives

By HospiMedica International staff writers
Posted on 01 Apr 2009
The quality of life of bladder cancer patients treated with robot-assisted cystectomy returned to normal within six months, according to a new study.

Researchers at Roswell Park Cancer Institute (RPCI, Buffalo, NY, USA) conducted a prospective study to examine the quality-of-life (QOL) benefits of robot-assisted cystectomy; QOL was examined using the Functional Assessment of Cancer Therapy questionnaire in 34 patients who underwent robot-assisted surgery between January 2006 and December 2007. More...
The patients were monitored according to U.S. National Comprehensive Cancer Center (NCCN, Fort Washington, PA, USA) guidelines. The average age of the patients was 65 years, and 88% were men. Of all patients, 13% received chemotherapy after surgery. QOL issues were assessed at 1-, 3-, and 6-month intervals.

The researchers found that physical well-being decreased significantly in the first follow-up visit due to the immediate impact of surgery. However, six months later, patients reported their physical activities were comparable with their activities prior to surgery. Emotional scores were statistically higher after surgery, indicating that feelings of sadness and anxiety appeared to be alleviated by the minimally invasive surgery and rapid postrecovery. Scores for social and family support remained uniformly high. The study was published in the March 2009 issue of the British Journal of Urology International (BJUI).

"Patients have indicated that the overall quality of their life after cancer surgery is as important as how long they survive. This study helps us to understand the patient's physical, social, emotional, and functional well-being after surgery," said lead author Khurshid Guru, M.D., director of the department of robotic surgery at RPCI. "Robot-assisted surgery continues to demonstrate its efficacy as a treatment for bladder cancer patients and has now shown its value to patients as they return to life after cancer."

Robot assisted surgery removal of the bladder provides patients with a less invasive treatment option that has several potential advantages over traditional open surgery, including less postoperative pain and fewer days spent in the hospital.

Related Links:

Roswell Park Cancer Institute
U.S. National Comprehensive Cancer Center




Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.